ABEONA THERAPEUTICS INC (ABEO) Institutional Selling Activity

Several institutional investors tracked by InsiderSet reduced exposure to ABEONA THERAPEUTICS INC (ABEO) during the quarter ended March 31, 2026 based on sequential SEC Form 13F filings.

The largest disclosed institutional seller of ABEO during the latest reporting period reduced its reported position by approximately $2.33M based on quarter-end filing values.

Institutional selling activity may reflect profit-taking, sector rotation, portfolio rebalancing, or changing conviction levels among major investment firms. InsiderSet tracks quarter-over-quarter holding reductions, full exits, estimated value changes, and historical selling activity using publicly disclosed SEC filing data.

The investors covered on this page collectively reduced approximately $4.75M in reported ABEO exposure during the latest filing period, although many institutional holders continue to maintain significant long-term ownership positions in ABEONA THERAPEUTICS INC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2025Renaissance Technologies LLCSell-410,237116,200$612,374
Q4 2024Renaissance Technologies LLCSell-45,04189,237$497,050
Q3 2024Renaissance Technologies LLCSell-369,015134,278$848,637
Q1 2024Renaissance Technologies LLCSell-108,55673,837$535
Q3 2023Renaissance Technologies LLCSell-2,70030,837$130
Q2 2023Renaissance Technologies LLCSell-3,30033,537$135
Q1 2023Renaissance Technologies LLCSell-25,80036,837$104
Q4 2022Renaissance Technologies LLCSell-5,50062,637$193

Frequently asked questions about ABEO activity

  • Which institutional owners are buying ABEO?

    Institutional owners buying ABEO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ABEO activity?

    "Buy" means an investor increased their reported position in ABEO compared to the prior reporting period. This reflects growing exposure to ABEONA THERAPEUTICS INC (ABEO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ABEO increasing?

    Institutional interest in ABEO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.